跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,116 条关于
“Cogent”
全部
3,116
临床试验
2,762
药物
106
机构
21
资讯
227
10个月前
Cogent Biosciences Unveils Promising KRAS Inhibitor Data with Superior Efficacy Profile
去年
Cogent Biosciences Secures $400M Debt Financing to Advance Bezuclastinib Through Pivotal Trials
去年
Cogent Bio Presents Bezuclastinib Data Highlighting Long-Term Benefits in Non-Advanced Systemic Mastocytosis
10个月前
Cogent Biosciences Raises $475.3 Million to Advance Bezuclastinib for Systemic Mastocytosis
去年
Cogent Biosciences' Bezuclastinib Shows Promise in Systemic Mastocytosis Trials
去年
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2024 Financial Results
前天
FDA Accepts Cogent Biosciences' NDA for Bezuclastinib in Advanced Systemic Mastocytosis, PDUFA Set for June 2027
去年
COGT Stock Hits 52-Week High at $12.2 Amid Market Optimism
去年
Bezuclastinib Achieves 87% Response Rate in Pivotal Trial for Non-Advanced Systemic Mastocytosis
7个月前
OnKure Faces Critical Data Readout for H1047R-Specific PI3Kα Inhibitor as Competition Intensifies
第 1 页,共 23 页
上一页
下一页